Targeting kinome reprogramming in ESR1 fusion-driven breast cancer

被引：0
|
作者：
Gou, Xuxu
Kim, Beom-Jun
Anurag, Meenakshi
Lei, Jonathan T.
Young, Meggie N.
Holt, Matthew V.
Fandino, Diana
Vollert, Craig T.
Singh, Purba
Alzubi, Mohammad A.
Malovannaya, Anna
Dobrolecki, Lacey E.
Lewis, Michael T.
Li, Shunqiang
Ellis, Matthew J.
Foulds, Charles E.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5011
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Targeting kinome reprogramming in ESR1 fusion-driven metastatic breast cancer.
    Gou, Xuxu
    Kim, Beom-Jun
    Anurag, Meenakshi
    Holt, Matthew Valle
    Young, Meggie Nguyen
    Lei, Jonathan Thomas
    Fandino, Diana
    Vollert, Craig T.
    Singh, Purba
    Alzubi, Mohammad A.
    Dobrolecki, Lacey Elizabeth
    Lewis, Michael
    Welm, Alana
    Li, Shunqiang
    Foulds, Charles Edward
    Ellis, Matthew James
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer
    Gou, Xuxu
    Kim, Beom-Jun
    Anurag, Meenakshi
    Lei, Jonathan T.
    Young, Meggie N.
    Holt, Matthew V.
    Fandino, Diana
    Vollert, Craig T.
    Singh, Purba
    Alzubi, Mohammad A.
    Malovannaya, Anna
    Dobrolecki, Lacey E.
    Lewis, Michael T.
    Li, Shunqiang
    Foulds, Charles E.
    Ellis, Matthew J.
    CANCER RESEARCH, 2023, 83 (19) : 3237 - 3251
  • [3] Targeting coactivators to inhibit ESR1 fusion-driven breast cancer growth
    Gou, Xuxu
    Vollert, Craig T.
    Chen, Yue
    Fandino, Diana
    Holt, Matthew V.
    Kim, Beom-Jun
    Feng, Qin
    Wang, Jin
    Lonard, David M.
    O'Malley, Bert W.
    Ellis, Matthew J.
    Foulds, Charles E.
    CANCER RESEARCH, 2023, 83 (08)
  • [4] Kinome reprogramming as a therapeutic opportunity in ESR1 fusion driven breast cancer but not in gynecologic cancers
    Turaga, Ravi Chakra
    Murali, Shivani Jagannathan
    Ivan, Cristina
    Karre, Bharath Kumar
    Sima, Chao
    Abera, Asfetaw
    Radovich, Milan
    O'Neill, Heather
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Novel clinical targets revealed by kinome reprogramming in mutant ESR1 metastatic breast cancer
    Dustin, Derek
    Gu, Guowei
    Chan, Doug
    Beyer, Amanda
    Edwards, David
    Corona-Rodriguez, Arnoldo
    Ellis, Matthew
    Fuqua, Suzanne
    CANCER RESEARCH, 2019, 79 (13)
  • [6] Targeting the PELP1 axis for treating ESR1 mutant driven breast cancer
    Altwegg, Kristin A.
    Viswanadhapalli, Suryavathi
    Liu, Junhao
    Liu, Zexuan
    Pratap, Uday P.
    Ebrahimi, Benham
    Vankayalapati, Hariprasad
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2021, 81 (04)
  • [7] Targeting ESR1 in breast cancer treatment: Repurposing of statins
    Kabir, E. R.
    Nausheen, N.
    Mustafa, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S442 - S442
  • [8] ESR1 mutations in breast cancer
    Clatot, Florian
    Augusto, Laetitia
    Di Fiore, Frederic
    AGING-US, 2017, 9 (01): : 17 - 18
  • [9] ESR1 mutations in breast cancer
    Dustin, Derek
    Gu, Guowei
    Fuqua, Suzanne A. W.
    CANCER, 2019, 125 (21) : 3714 - 3728
  • [10] On the evidence for ESR1 amplification in breast cancer
    Frederik Holst
    Cathy B. Moelans
    Martin Filipits
    Christian F. Singer
    Ronald Simon
    Paul J. van Diest
    Nature Reviews Cancer, 2012, 12 : 149 - 149
12345